Introduction
Pancreatic tuberculosis (TB) is an extremely rare clinical entity even in countries with high endemism [1] . Men and women are affected equally, with a mean age of approximately 40 years [2] . It usually occurs as a complication of miliary TB and immunodeficiency, with isolated involvement of the pancreas being extremely rare. It is frequently misdiagnosed as pancreatic neoplasm. Lately, the increased incidence of this entity is related to the frequency of abdominal TB in immunocompromised patients and the improvement in imaging methods of the pancreas. Because the clinical and radiographic presentation mimics pancreatic cancer, its diagnosis is a clinical challenge, and most cases are diagnosed after surgical exploration. The tuberculin skin test is useful in the diagnosis of pancreatic TB, but it has a false-negative rate of 10%e25% [3] . The definitive diagnosis rests on histologic and bacteriologic evidence of TB.
Pancreatic TB should be kept in mind among the differential diagnosis of pancreatic solitary masses, especially in young people in developing countries [4] . Detecting Mycobacterium tuberculosis DNA by a polymerase chain reaction in the tissue obtained from the lesion allows sameday results, with up to 77% sensitivities, although sample contamination and poor assay design can result in false negatives. Advancement in gene amplification techniques can now identify genes associated with antibiotic resistance but cannot give information regarding drug sensitivities, and, therefore, this test is an adjunct to standard culture techniques [5] . Early diagnosis is important to avoid unnecessary diagnostic or therapeutic procedures, because pancreatic TB is treated medically with excellent results [6] .
The available literature related to pancreatic TB is mostly in the form of case reports or series. We present our experience and the imaging features associated with it, with emphasis placed on computed tomography (CT), so to become familiar with the uncommon and difficult appearance of pancreatic TB and to emphasize the common neoplastic differential it can imitate. Our objective was to review the imaging findings of patients with pancreatic TB who presented with a pancreatic mass that turned out to be pancreatic TB. The spectrum of imaging findings will be reviewed and the distinction from other neoplasms was attempted.
Materials and Methods
The records of 14 patients (9 men and 5 women, with ages that ranged from 42e70 years and a mean age of 56 years) presented with pancreatic masses on CT and proven histologic diagnosis of pancreatic TB were reviewed retrospectively. The diagnosis was based on granuloma with caseation necrosis on histopathology or the presence of acid-fast bacilli. CT examinations were performed by using a General Electric Light Speed Scanner (GE light speed 4 Â 16-row; General Electric, Milwaukee, MI) and reviewed on proprietary work stations by using multiplanar reconstructions, which was performed for all the patients.
Noncontrast upper abdomen scanning acquisition was performed with 5 Â 5-mm slice thickness after oral intake of 3 cups of water an hour before the procedure. Followed by intravenous injection of 120 mL. Omnipaque 300 mg/mL at 2 mL/s by using a pump injector at a rate of 3e4 mL/s. Images were acquired in the pancreatic arterial and portal venous phases of contrast enhancement (20 and 60 seconds after injection, respectively) by using 30e40 collimations, reconstructed at 2.5-mm (arterial phase) or 5-mm (portal venous phase) increments, with slice thickness of 2.5 mm and 5 mm, respectively. The table feed is 12 mm per rotation. In 1 patient, oral contrast was administered instead of water to delineate the ileocecal junction region, because the patient presented with right iliac fossa pain.
In 3 patients, 1-run chest and abdominal scannings were performed at the portovenous phase because of concomitant thoracic and neurologic signs and symptoms. Fine needle aspiration (FNA), either ultrasonography (US) or CT guided, were performed for all the patients after CT scanning and documentation of presence of pancreatic masses or peripancreatic lymph nodes.
Nine patients underwent CT-guided FNA, whereas 5 underwent endoscopic ultrasound (EUS)-guided FNA. CTguided FNA was performed by placing the patient supine on the CT table, after informed consent. With using the aseptic technique, several passes into the pancreatic lesion were obtained. A cytologist on standby in the control room confirmed sufficient material has been obtained. All FNAs were successful, except 2 attempts of EUS-FNA failed because of tough tissue, which did not permit the needle penetration and had to be repeated.
Results

Clinical Finding
Presenting symptoms in all 14 patients consisted of general weakness, malaise, fever, weight loss, and upper abdominal pain that was localized to the right upper quadrant in 7 patients (50%); in 1 patient, the abdominal pain was more towards the right iliac fossa (7%). Night sweats, hemoptysis, and productive cough were present in 3 patients (21%). Cervical lymphadenopathy and painful right axillary swelling were present in 1 patient (7%), whereas severe back pain with lower limb weakness was present in another one (7%).
Histopathology
FNA was obtained from pancreatic masses in 8 patients, and from peripancreatic lymph nodes in 6 patients. In addition, FNA was obtained from right axillary swellings in 1 patient. Cytopathology from the pancreatic masses, peripancreatic nodes, and right axillary swelling of 11 patients revealed granulomas composed of nodular aggregates of epithelioid histiocytic nuclei on a background of inflammatory and necrotic debris, as well as occasional multinucleated giant cells.
In 3 patients, the FNA results were inconclusive. No malignant cells were revealed in any of the FNA results. Ziehl-Neelsen stain was positive for acid fast bacilli in 6 patients. Cultures of the FNA aspirates grew colonies of Mycobacterium tuberculosis after 4 weeks of inoculation in 7 cases of these the 3 cases with inconclusive FNA results at cytopathologic assessment. In all the patients, pancreatic TB was confirmed by improvement of abnormalities on abdominal CT after administration of antituberculous chemotherapy.
CT Findings
A focal mass of low attenuation relative to the enhancing pancreatic parenchyma at the pancreatic head was present in 5 patients (36%) (Figures 1 and 2) . One of these patients presented with diffuse coarse pancreatic calcifications and dilatation of the pancreatic duct, with distal pancreatic atrophy indistinguishable from adenocarcinoma (Figure 2) . A cystic mass with a peripheral rim of enhancement at the pancreatic head was present in 3 patients (21%). Low attenuation peripancreatic adenopathy with peripheral rim enhancement was the most common finding, because it was seen in 6 patients (43%) ( Figures 3A and 4A) (Table 1) .
Extra-abdominal Manifestations
Three of the patients (21%) presented with concomitant thoracic findings that were suggestive of TB on 1-run chest and abdominal scanning:
Diffuse randomly distributed micronodular opacities in both lungs in keeping with miliary TB were present in 1 patient. Loculated pleural effusions and multiple chest wall cystic lesions that were encroaching upon the right 6th dorsal nerve were present in another patient (Figure 3 ). A large cystic mass, with enhancing wall at the right axilla revealed to be large necrotic TB adenitis was present in 1 patient.
In all the patients, TB was documented by FNA, and a follow-up CT after an average period of 8 months revealed significant interval regression of the pancreatic masses and peripancreatic lymph nodes ( Figure 4B ). Pancreatic TB was strongly suspected in patients with combined pancreatic lesion and peripancreatic hypoattenuating lymph nodes as well clinical findings suspicious of TB as night sweats, anorexia, and weight loss, especially with positive purified protein derivative (PPD) test.
Discussion
Pancreatic TB is very rare [7] . In a review study of 1,656 autopsies of patients with TB, pancreatic involvement was seen in only 4.7% of patients [8] . The common clinical presentations in pancreatic TB are nonspecific, as vague epigastric pain, weight loss, and low-grade fever indistinguishable from pancreatic malignancy. Pancreatic cancer was the leading diagnosis in all the 17 case reports of pancreatic TB until the availability of pancreatic tissue for pathologic examination [6] . Although erythrocyte sedimentation rate (ESR) is a nonspecific marker, it has been shown to be elevated in most patients with pancreatic TB [9] .
There is a large spectrum in the CT findings of pancreatic TB in the literature, which is limited to individual case reports or small series. These CT findings include a focal mass of low attenuation [6] , a cystic mass [10] , small nodular lesions [11] , pancreatic calcification [12] , and focal [13] and diffuse enlargement of the pancreas [12] .The most common CT manifestation of pancreatic TB is a mass [12, 14] , which was difficult to differentiate from pancreatic carcinoma. The majority of tuberculous pancreatic masses occur in the head [9, 10, 14, 15] , which is also the case for pancreatic carcinoma [16] . Similarly, in this study, most of the patients presented with a focal mass either of low or cystic attenuation at the pancreatic head indistinguishable from pancreatic carcinoma. The hypoattenuating focal mass was encountered in 5 cases (Figure 1 ) that mimics adenocarcinoma, which is more commonly associated with secondary signs, such as interruption of the pancreatic duct, distal pancreatic atrophy, and mass effect. The focal cystic lesions seen in 3 patients in this study mimicked cystic neoplasms (Figure 3 ) [14] .
In pancreatic carcinoma, the hypoattenuating appearance may be because of central necrosis, or more commonly, because of differential contrast enhancement by tumour tissue and normal pancreas. In pancreatic TB, the nonenhancing areas may represent caseated necrosis or pus [16] . It is possible for pancreatic TB to result from hematogenous spread, such as with 3 of our patients with miliary lung TB, paravertebral TB abscesses, and axillary necrotic TB adenitis with pancreatic involvement (Figure 3 ). Although the most likely mechanism is probably by contiguous spread from adjacent peripancreatic lymph nodes [11] , which was noted in 6 of our patients (Figure 4) .
Compared with abdominal and endoscopic US, multidetector computed tomography (MDCT) is an excellent modality for pancreatic imaging; it enables high-quality multiplanar reconstructions to be generated. Combined with the fast acquisition time, which allows optimum visualization of both arterial and venous anatomy, 1-run chest and abdominal CT scanning is a plus to rule out concomitant findings suggestive of TB, because a diagnosis of TB can be suggested on CT only in the presence of ancillary findings like pulmonary TB, pleural effusion, enlarged celiac lymph nodes, lesions in other solid viscera, ascites, and mural thickening in the ileocecal region as encountered in 3 of our patients.
CT-guided percutaneous FNA of pancreatic masses to obtain proof of the bacilli by the Ziehl-Neelsen stain or by culture is 1 diagnostic option; however, the aspiration of material from peripancreatic tumours or lymph nodes may be difficult; it was positive in 35% of cases of abdominal TB studied by Koduri et al [17] , although it was positive in all of our cases.
Ziehl-Neelsen stain is quick and simple but sensitive in only 50% cases. Cultures are sensitive (77%) and provide antibiotic sensitivities but can take up to 8 weeks, which can delay the diagnosis [18, 19] . Furthermore, the potential risk of tumour dissemination sometimes prevents the physician from performing FNA [4] . EUS-guided FNA (EUS-FNA) is being used more frequently for imaging and sampling of pancreatic lesions when there is no clear-cut clinical or radiologic feature to suggest a pancreatic mass is neoplastic or infective [1] . Compared with CT-guided FNA, the risk of tumour seeding with EUS-FNA of malignant lesions is very low [20] , and many endosonographers routinely perform FNA of such lesions. However, EUS-FNA is a technically difficult procedure, with a learning curve that is considerably longer than for percutaneous FNA when using CT guidance [21] .
In our series, follow-up CT was done after an average period of 8 months after the initial scan and anti-TB treatment that showed complete resolution of the pancreatic masses and peripancreatic lymph nodes in all the patients, so, CT is also useful for documentation of resolution.
Conclusion
Pancreatic TB is rare. It can mimic pancreatic carcinoma both clinically and radiologically. Hence, histologic diagnosis is important before appropriate medical therapy can be instituted.
